Arvee Laboratories (India) Ltd
Company Profile
Business description
Arvee Laboratories (India) Ltd is a specialty chemical company. The company operates in two segments namely- bulk chemicals and specialty chemicals. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, operations and revenue are concentrated within India markets expanding their exports in Asia- Pacific markets.
Contact
Iskcon Bopal Road
403, Entice Building
Opposite Jayantilal Park BRTS Bus Stop
Ambli
AhmedabadGJ380058
INDT: +91 2717430479
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 March 2027
Employees
57
Stocks News & Analysis
stocks
An undervalued stock to buy that even Warren Buffett likes
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,850.70 | 5.10 | 0.06% |
| CAC 40 | 8,131.06 | 53.26 | 0.66% |
| DAX 40 | 25,509.05 | 100.41 | 0.40% |
| Dow JONES (US) | 51,569.93 | 258.69 | -0.50% |
| FTSE 100 | 10,745.76 | 50.51 | 0.47% |
| HKSE | 24,642.51 | 132.42 | 0.54% |
| NASDAQ | 26,921.80 | 146.91 | -0.54% |
| Nikkei 225 | 65,877.62 | 486.59 | -0.73% |
| NZX 50 Index | 13,830.68 | 19.57 | 0.14% |
| S&P 500 | 7,710.36 | 33.05 | -0.43% |
| S&P/ASX 200 | 8,679.70 | 14.70 | 0.17% |
| SSE Composite Index | 3,823.62 | 64.75 | -1.67% |